doi: 10.1007/s13311-017-0585-0 25 DetkaJlusarczykJKurekAKucharczykMAdamusTKoniecznyPet al
Favorable Metabolic Effects GLP-1R agonists has shown to reduce the effects of several atherosclerotic cardiovascular disease (ASCVD) metabolic risk factors including diabetes mellitus, hyperlipidemia, overweight and obesity, and hepatic steatosis [68]
Lancet 393:3139 Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, EMPA-REG OUTCOME Investigators et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
GHK has been suggested to quench 4-hydroxy-trans-2-nonenal (4-HNE) and acrolein, both toxic aldehydes generated during lipid peroxidation, suggesting the tripeptide backbone itself may carry electrophile-scavenging capacity independent of its metal-chelating role
There are nine different ones, including lysine, leucine, isoleucine, phenylalanine, threonine, histidine, methionine, tryptophan and valine
IL-24 treatment downregulated the expression of several tight junction components 67 and associated signaling proteins responsible for junctional integrity 68 (Fig
